Asia Pacific Glucoamylase Market Size & Outlook, 2026-2034


Asia Pacific Glucoamylase Market Insights

  • As highlighted in Reed Intelligence analysis, the Asia Pacific Glucoamylase Market, valued at USD 212.73 Million in 2025, is estimated to achieve USD 402.08 Million by 2034.
  • The market is estimated to grow at a CAGR of 7.3% spanning 2026 to 2034.
  • By market size, Microbial Glucoamylase led the Type category in 2025.
  • The Type segment led by Plant-Based Glucoamylase is estimated to post the fastest growth, sustaining its position as the most lucrative during the forecast timeframe.

Other Key Findings


  • The global Glucoamylase Market size saw Asia Pacific holding a share of 20.26% in 2025.
  • United States is forecasted to account for the leading share of the global market by 2034.
  • In Asia Pacific, South Korea is forecasted to be the fastest-expanding market, projected to reach USD 20.65 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 212.73 Million
Market Size In 2034 USD 402.08 Million
Largest segment Microbial Glucoamylase
Units Revenue in USD Million
CAGR 7.3% (2026-2034)
Segmnetation Covered
Asia Pacific
  1. China
  2. India
  3. Japan
  4. South Korea
  5. Taiwan
  6. Australia
  7. Singapore
  8. South East Asia
Type
  1. Microbial Glucoamylase
  2. Plant-Based Glucoamylase
  3. Genetically Engineered Glucoamylase
Application
  1. Food & Beverage Processing
  2. Bioethanol Production
  3. Animal Feed
  4. Pharmaceuticals
End-Use Industry
  1. Food & Beverage Industry
  2. Energy & Biofuel Industry
  3. Pharmaceutical & Biotechnology Industry
  4. Agriculture Industry
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
clients
Trusted by Fortune 500
Over 30000+ subscribers